Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis
Please cite this paper as: Myung S, Ju W, Jung H, Park C, Oh S, Seo H, Kim H, for the Korean Meta‐Analysis (KORMA) Study Group. Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta‐analysis. BJOG 2012;119:1029–1039. Background The efficacy and safety of pharma...
Gespeichert in:
| Veröffentlicht in: | BJOG : an international journal of obstetrics and gynaecology 2012-08, Vol.119 (9), p.1029-1039 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1039 |
|---|---|
| container_issue | 9 |
| container_start_page | 1029 |
| container_title | BJOG : an international journal of obstetrics and gynaecology |
| container_volume | 119 |
| creator | Myung, S-K Ju, W Jung, H-S Park, C-H Oh, S-W Seo, HG Kim, HS |
| description | Please cite this paper as: Myung S, Ju W, Jung H, Park C, Oh S, Seo H, Kim H, for the Korean Meta‐Analysis (KORMA) Study Group. Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta‐analysis. BJOG 2012;119:1029–1039.
Background The efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers has not yet been established.
Objective To investigate the efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers.
Search strategy A search was made of PubMed, Embase and CENTRAL in June 2011.
Selection criteria Randomised controlled trials (RCTs), quasi‐RCTs and retrospective or prospective controlled studies were included.
Data collection and analysis The main analyses were designed to examine the efficacy of pharmacotherapy for smoking cessation among pregnant smokers based on the longest follow‐up data available and from data obtained at the latest available time‐point in pregnancy in each study.
Main results Of 74 articles identified from the databases, seven studies (five RCTs, one quasi‐RCT and one prospective study) involving a total of 1386 pregnant smokers, 732 in the intervention groups and 654 in the control groups, were included in the final analyses. In a fixed‐effects meta‐analysis of all seven studies based on the longest follow‐up data available, pharmacotherapy had a significant effect on smoking cessation (relative risk [RR] 1.80; 95% confidence interval [CI] 1.32–2.44). Subgroup meta‐analysis by type of study design also showed similar findings for RCTs (RR 1.48; 95% CI 1.04–2.09) and other types of studies (RR 3.25; 95% CI 1.65–6.39). The abstinence rate at late pregnancy in the intervention ranged from 7 to 22.6% (mean abstinence rate 13.0%; 95% CI 10.9–15.2%). A few minor adverse effects and serious adverse effects were reported in several studies.
Author’s conclusions This study indicates that there may be clinical evidence to support the use of pharmacotherapy for smoking cessation among pregnant smokers. Further RCTs are needed. |
| doi_str_mv | 10.1111/j.1471-0528.2012.03408.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1032888086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1032888086</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4988-aa6bb3951f1d4e11888b24d0493971a335ca8e5d638620dbc8f2261892e51fa93</originalsourceid><addsrcrecordid>eNqNkUtv1DAUhSMEoqXwF5AlhMQmwY88bpBYlFE7gCraRSsQG-vGsdtMkzjYGXXy73FmhqnEqt74Wv6Ofc-5UUQYTVhYH1cJSwsW04xDwinjCRUphWTzLDo-XDzf1jSmgsNR9Mr7FaUs51S8jI44L4ACg-OoPjOmUagmgn1NPBo9TsQaMtyh61DZ8U47HCZirCO-s_dNf0uU9h7HxvYEOxvOg9O3PfbjFtDOfyJIOj1ijD22k2_86-iFwdbrN_v9JLo5P7tefI0vLpffFqcXsUpLgBgxrypRZsywOtWMAUDF05qmpSgLhkJkCkFndS4g-KgrBYbznEHJddBgKU6iD7t3B2f_rLUfZdd4pdsWe23XXrI5CwjO84C--w9d2bUL_c4UT3kGHFigYEcpZ7132sjBNR26KUBynoRcyTlwOQcu50nI7STkJkjf7j9YV52uD8J_0Qfg_R5Ar7A1DnvV-EcuZxQ4m0193nEPTaunJzcgv3y_nKugj3f6xo96c9Cju5d5IYpM_vyxlFe_2fJ68auQmfgL0QSyUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1024258281</pqid></control><display><type>article</type><title>Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Myung, S-K ; Ju, W ; Jung, H-S ; Park, C-H ; Oh, S-W ; Seo, HG ; Kim, HS</creator><creatorcontrib>Myung, S-K ; Ju, W ; Jung, H-S ; Park, C-H ; Oh, S-W ; Seo, HG ; Kim, HS ; Korean Meta-Analysis (KORMA) Study Group ; for the Korean Meta‐Analysis (KORMA) Study Group</creatorcontrib><description>Please cite this paper as: Myung S, Ju W, Jung H, Park C, Oh S, Seo H, Kim H, for the Korean Meta‐Analysis (KORMA) Study Group. Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta‐analysis. BJOG 2012;119:1029–1039.
Background The efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers has not yet been established.
Objective To investigate the efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers.
Search strategy A search was made of PubMed, Embase and CENTRAL in June 2011.
Selection criteria Randomised controlled trials (RCTs), quasi‐RCTs and retrospective or prospective controlled studies were included.
Data collection and analysis The main analyses were designed to examine the efficacy of pharmacotherapy for smoking cessation among pregnant smokers based on the longest follow‐up data available and from data obtained at the latest available time‐point in pregnancy in each study.
Main results Of 74 articles identified from the databases, seven studies (five RCTs, one quasi‐RCT and one prospective study) involving a total of 1386 pregnant smokers, 732 in the intervention groups and 654 in the control groups, were included in the final analyses. In a fixed‐effects meta‐analysis of all seven studies based on the longest follow‐up data available, pharmacotherapy had a significant effect on smoking cessation (relative risk [RR] 1.80; 95% confidence interval [CI] 1.32–2.44). Subgroup meta‐analysis by type of study design also showed similar findings for RCTs (RR 1.48; 95% CI 1.04–2.09) and other types of studies (RR 3.25; 95% CI 1.65–6.39). The abstinence rate at late pregnancy in the intervention ranged from 7 to 22.6% (mean abstinence rate 13.0%; 95% CI 10.9–15.2%). A few minor adverse effects and serious adverse effects were reported in several studies.
Author’s conclusions This study indicates that there may be clinical evidence to support the use of pharmacotherapy for smoking cessation among pregnant smokers. Further RCTs are needed.</description><identifier>ISSN: 1470-0328</identifier><identifier>EISSN: 1471-0528</identifier><identifier>DOI: 10.1111/j.1471-0528.2012.03408.x</identifier><identifier>PMID: 22780818</identifier><identifier>CODEN: BIOGFQ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Benzazepines - therapeutic use ; Biological and medical sciences ; Bupropion - therapeutic use ; Clinical trials ; Controlled Clinical Trials as Topic ; Dopamine Uptake Inhibitors - therapeutic use ; Drug therapy ; Epidemiologic Methods ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; Meta-analysis ; Nicotinic Agonists - therapeutic use ; pharmacotherapy ; Pregnancy ; Pregnancy Complications - chemically induced ; Pregnancy Complications - prevention & control ; Pregnancy Outcome ; pregnant smokers ; Quinoxalines - therapeutic use ; Smoking cessation ; Smoking Cessation - methods ; Tobacco Use Cessation Products ; Tobacco, tobacco smoking ; Toxicology ; Varenicline ; Young Adult</subject><ispartof>BJOG : an international journal of obstetrics and gynaecology, 2012-08, Vol.119 (9), p.1029-1039</ispartof><rights>2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG</rights><rights>2015 INIST-CNRS</rights><rights>2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4988-aa6bb3951f1d4e11888b24d0493971a335ca8e5d638620dbc8f2261892e51fa93</citedby><cites>FETCH-LOGICAL-c4988-aa6bb3951f1d4e11888b24d0493971a335ca8e5d638620dbc8f2261892e51fa93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1471-0528.2012.03408.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1471-0528.2012.03408.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26108219$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22780818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Myung, S-K</creatorcontrib><creatorcontrib>Ju, W</creatorcontrib><creatorcontrib>Jung, H-S</creatorcontrib><creatorcontrib>Park, C-H</creatorcontrib><creatorcontrib>Oh, S-W</creatorcontrib><creatorcontrib>Seo, HG</creatorcontrib><creatorcontrib>Kim, HS</creatorcontrib><creatorcontrib>Korean Meta-Analysis (KORMA) Study Group</creatorcontrib><creatorcontrib>for the Korean Meta‐Analysis (KORMA) Study Group</creatorcontrib><title>Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis</title><title>BJOG : an international journal of obstetrics and gynaecology</title><addtitle>BJOG</addtitle><description>Please cite this paper as: Myung S, Ju W, Jung H, Park C, Oh S, Seo H, Kim H, for the Korean Meta‐Analysis (KORMA) Study Group. Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta‐analysis. BJOG 2012;119:1029–1039.
Background The efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers has not yet been established.
Objective To investigate the efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers.
Search strategy A search was made of PubMed, Embase and CENTRAL in June 2011.
Selection criteria Randomised controlled trials (RCTs), quasi‐RCTs and retrospective or prospective controlled studies were included.
Data collection and analysis The main analyses were designed to examine the efficacy of pharmacotherapy for smoking cessation among pregnant smokers based on the longest follow‐up data available and from data obtained at the latest available time‐point in pregnancy in each study.
Main results Of 74 articles identified from the databases, seven studies (five RCTs, one quasi‐RCT and one prospective study) involving a total of 1386 pregnant smokers, 732 in the intervention groups and 654 in the control groups, were included in the final analyses. In a fixed‐effects meta‐analysis of all seven studies based on the longest follow‐up data available, pharmacotherapy had a significant effect on smoking cessation (relative risk [RR] 1.80; 95% confidence interval [CI] 1.32–2.44). Subgroup meta‐analysis by type of study design also showed similar findings for RCTs (RR 1.48; 95% CI 1.04–2.09) and other types of studies (RR 3.25; 95% CI 1.65–6.39). The abstinence rate at late pregnancy in the intervention ranged from 7 to 22.6% (mean abstinence rate 13.0%; 95% CI 10.9–15.2%). A few minor adverse effects and serious adverse effects were reported in several studies.
Author’s conclusions This study indicates that there may be clinical evidence to support the use of pharmacotherapy for smoking cessation among pregnant smokers. Further RCTs are needed.</description><subject>Adult</subject><subject>Benzazepines - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Bupropion - therapeutic use</subject><subject>Clinical trials</subject><subject>Controlled Clinical Trials as Topic</subject><subject>Dopamine Uptake Inhibitors - therapeutic use</subject><subject>Drug therapy</subject><subject>Epidemiologic Methods</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Meta-analysis</subject><subject>Nicotinic Agonists - therapeutic use</subject><subject>pharmacotherapy</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - chemically induced</subject><subject>Pregnancy Complications - prevention & control</subject><subject>Pregnancy Outcome</subject><subject>pregnant smokers</subject><subject>Quinoxalines - therapeutic use</subject><subject>Smoking cessation</subject><subject>Smoking Cessation - methods</subject><subject>Tobacco Use Cessation Products</subject><subject>Tobacco, tobacco smoking</subject><subject>Toxicology</subject><subject>Varenicline</subject><subject>Young Adult</subject><issn>1470-0328</issn><issn>1471-0528</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtv1DAUhSMEoqXwF5AlhMQmwY88bpBYlFE7gCraRSsQG-vGsdtMkzjYGXXy73FmhqnEqt74Wv6Ofc-5UUQYTVhYH1cJSwsW04xDwinjCRUphWTzLDo-XDzf1jSmgsNR9Mr7FaUs51S8jI44L4ACg-OoPjOmUagmgn1NPBo9TsQaMtyh61DZ8U47HCZirCO-s_dNf0uU9h7HxvYEOxvOg9O3PfbjFtDOfyJIOj1ijD22k2_86-iFwdbrN_v9JLo5P7tefI0vLpffFqcXsUpLgBgxrypRZsywOtWMAUDF05qmpSgLhkJkCkFndS4g-KgrBYbznEHJddBgKU6iD7t3B2f_rLUfZdd4pdsWe23XXrI5CwjO84C--w9d2bUL_c4UT3kGHFigYEcpZ7132sjBNR26KUBynoRcyTlwOQcu50nI7STkJkjf7j9YV52uD8J_0Qfg_R5Ar7A1DnvV-EcuZxQ4m0193nEPTaunJzcgv3y_nKugj3f6xo96c9Cju5d5IYpM_vyxlFe_2fJ68auQmfgL0QSyUQ</recordid><startdate>201208</startdate><enddate>201208</enddate><creator>Myung, S-K</creator><creator>Ju, W</creator><creator>Jung, H-S</creator><creator>Park, C-H</creator><creator>Oh, S-W</creator><creator>Seo, HG</creator><creator>Kim, HS</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope></search><sort><creationdate>201208</creationdate><title>Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis</title><author>Myung, S-K ; Ju, W ; Jung, H-S ; Park, C-H ; Oh, S-W ; Seo, HG ; Kim, HS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4988-aa6bb3951f1d4e11888b24d0493971a335ca8e5d638620dbc8f2261892e51fa93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Benzazepines - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Bupropion - therapeutic use</topic><topic>Clinical trials</topic><topic>Controlled Clinical Trials as Topic</topic><topic>Dopamine Uptake Inhibitors - therapeutic use</topic><topic>Drug therapy</topic><topic>Epidemiologic Methods</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Meta-analysis</topic><topic>Nicotinic Agonists - therapeutic use</topic><topic>pharmacotherapy</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - chemically induced</topic><topic>Pregnancy Complications - prevention & control</topic><topic>Pregnancy Outcome</topic><topic>pregnant smokers</topic><topic>Quinoxalines - therapeutic use</topic><topic>Smoking cessation</topic><topic>Smoking Cessation - methods</topic><topic>Tobacco Use Cessation Products</topic><topic>Tobacco, tobacco smoking</topic><topic>Toxicology</topic><topic>Varenicline</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Myung, S-K</creatorcontrib><creatorcontrib>Ju, W</creatorcontrib><creatorcontrib>Jung, H-S</creatorcontrib><creatorcontrib>Park, C-H</creatorcontrib><creatorcontrib>Oh, S-W</creatorcontrib><creatorcontrib>Seo, HG</creatorcontrib><creatorcontrib>Kim, HS</creatorcontrib><creatorcontrib>Korean Meta-Analysis (KORMA) Study Group</creatorcontrib><creatorcontrib>for the Korean Meta‐Analysis (KORMA) Study Group</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>BJOG : an international journal of obstetrics and gynaecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Myung, S-K</au><au>Ju, W</au><au>Jung, H-S</au><au>Park, C-H</au><au>Oh, S-W</au><au>Seo, HG</au><au>Kim, HS</au><aucorp>Korean Meta-Analysis (KORMA) Study Group</aucorp><aucorp>for the Korean Meta‐Analysis (KORMA) Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis</atitle><jtitle>BJOG : an international journal of obstetrics and gynaecology</jtitle><addtitle>BJOG</addtitle><date>2012-08</date><risdate>2012</risdate><volume>119</volume><issue>9</issue><spage>1029</spage><epage>1039</epage><pages>1029-1039</pages><issn>1470-0328</issn><eissn>1471-0528</eissn><coden>BIOGFQ</coden><abstract>Please cite this paper as: Myung S, Ju W, Jung H, Park C, Oh S, Seo H, Kim H, for the Korean Meta‐Analysis (KORMA) Study Group. Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta‐analysis. BJOG 2012;119:1029–1039.
Background The efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers has not yet been established.
Objective To investigate the efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers.
Search strategy A search was made of PubMed, Embase and CENTRAL in June 2011.
Selection criteria Randomised controlled trials (RCTs), quasi‐RCTs and retrospective or prospective controlled studies were included.
Data collection and analysis The main analyses were designed to examine the efficacy of pharmacotherapy for smoking cessation among pregnant smokers based on the longest follow‐up data available and from data obtained at the latest available time‐point in pregnancy in each study.
Main results Of 74 articles identified from the databases, seven studies (five RCTs, one quasi‐RCT and one prospective study) involving a total of 1386 pregnant smokers, 732 in the intervention groups and 654 in the control groups, were included in the final analyses. In a fixed‐effects meta‐analysis of all seven studies based on the longest follow‐up data available, pharmacotherapy had a significant effect on smoking cessation (relative risk [RR] 1.80; 95% confidence interval [CI] 1.32–2.44). Subgroup meta‐analysis by type of study design also showed similar findings for RCTs (RR 1.48; 95% CI 1.04–2.09) and other types of studies (RR 3.25; 95% CI 1.65–6.39). The abstinence rate at late pregnancy in the intervention ranged from 7 to 22.6% (mean abstinence rate 13.0%; 95% CI 10.9–15.2%). A few minor adverse effects and serious adverse effects were reported in several studies.
Author’s conclusions This study indicates that there may be clinical evidence to support the use of pharmacotherapy for smoking cessation among pregnant smokers. Further RCTs are needed.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>22780818</pmid><doi>10.1111/j.1471-0528.2012.03408.x</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1470-0328 |
| ispartof | BJOG : an international journal of obstetrics and gynaecology, 2012-08, Vol.119 (9), p.1029-1039 |
| issn | 1470-0328 1471-0528 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1032888086 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Adult Benzazepines - therapeutic use Biological and medical sciences Bupropion - therapeutic use Clinical trials Controlled Clinical Trials as Topic Dopamine Uptake Inhibitors - therapeutic use Drug therapy Epidemiologic Methods Female Gynecology. Andrology. Obstetrics Humans Medical sciences Meta-analysis Nicotinic Agonists - therapeutic use pharmacotherapy Pregnancy Pregnancy Complications - chemically induced Pregnancy Complications - prevention & control Pregnancy Outcome pregnant smokers Quinoxalines - therapeutic use Smoking cessation Smoking Cessation - methods Tobacco Use Cessation Products Tobacco, tobacco smoking Toxicology Varenicline Young Adult |
| title | Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A49%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20safety%20of%20pharmacotherapy%20for%20smoking%20cessation%20among%20pregnant%20smokers:%20a%20meta-analysis&rft.jtitle=BJOG%20:%20an%20international%20journal%20of%20obstetrics%20and%20gynaecology&rft.au=Myung,%20S-K&rft.aucorp=Korean%20Meta-Analysis%20(KORMA)%20Study%20Group&rft.date=2012-08&rft.volume=119&rft.issue=9&rft.spage=1029&rft.epage=1039&rft.pages=1029-1039&rft.issn=1470-0328&rft.eissn=1471-0528&rft.coden=BIOGFQ&rft_id=info:doi/10.1111/j.1471-0528.2012.03408.x&rft_dat=%3Cproquest_cross%3E1032888086%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1024258281&rft_id=info:pmid/22780818&rfr_iscdi=true |